Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JonB
    Member
    • Jan 2010
    • 85

    Need advice on analysing RNA-seq time series

    Hi everyone,

    I have performed RNA-seq from different stages of embryogenesis. Some stages have two, three or four replicates, while some have none. I want to identify a set of genes that I can say are associated with embryogenesis in general - of all stages.

    What I have done so far is to use DESeq2 and performed pairwise DE-tests between all the different stages and extracted the significant genes from each test, pooled them and extracted the unique genes. But I am not sure if this is the best way (or even a correct way) to do it. And I guess I should perform some kind of statistical test on my procedure, like permutations or something.

    Any advice on how to analyse this data is greatly appreciated.

    Thanks,

    Jon
  • Michael Love
    Senior Member
    • Jul 2013
    • 333

    #2
    hi Jon,

    The likelihood ratio test (see the section in the vignette) can be used to test for differences at any stage. Here, you specify a reduced formula where you remove the stage variable from the design (so if your design is ~ stage, then reduced = ~ 1).

    Mike

    Comment

    • JonB
      Member
      • Jan 2010
      • 85

      #3
      Originally posted by Michael Love View Post
      hi Jon,

      The likelihood ratio test (see the section in the vignette) can be used to test for differences at any stage. Here, you specify a reduced formula where you remove the stage variable from the design (so if your design is ~ stage, then reduced = ~ 1).

      Mike
      Thanks!

      Jon

      Comment

      • JonB
        Member
        • Jan 2010
        • 85

        #4
        Originally posted by Michael Love View Post
        hi Jon,

        The likelihood ratio test (see the section in the vignette) can be used to test for differences at any stage. Here, you specify a reduced formula where you remove the stage variable from the design (so if your design is ~ stage, then reduced = ~ 1).

        Mike
        Dear Mike,

        Sorry for asking novice questions.
        I have only one variable to my design (condition) that includes all the different stages as well as the non-reproductive stages (which I want to use as controls). When I created the dataset I used design = ~ condition, but will this be correct if I want to use reduced = ~ 1 as you suggested?

        Jon

        Comment

        • Michael Love
          Senior Member
          • Jul 2013
          • 333

          #5
          Using full = ~ condition and reduced = ~ 1 tests for any difference in counts related to the levels of condition. this will include genes where stage 1 is different than control, and genes where stage 2 is different than stage 1, etc.

          Comment

          • Wallysb01
            Senior Member
            • Feb 2011
            • 286

            #6
            The basic idea here is you’re looking for genes in which the beta term in the equation expression = beta * stage + constant is significantly different from zero. This is a generalized linear model.

            So you’re not going to get genes that are just different between stage 1 and stage 2, then do what ever else in stages 3-5 or what not. You’re going to be finding genes that consistently show a trend, up or down, as stage progresses.

            You can also put any other confounding variables in there. So if you have different batches of embryos in any way or different sequencing run/library prep days, you may want to try to control for that by adding another variable (design = ~ condition + batch, reduce = ~ batch).

            Comment

            • Michael Love
              Senior Member
              • Jul 2013
              • 333

              #7
              hi Wally,

              re: "show a trend" that would be true if stage was a numeric, but I guess Jon coded it is a factor.

              Comment

              Latest Articles

              Collapse

              • mylaser
                Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by mylaser
                Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
                If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
                This guide explains everything you need to know about...
                Yesterday, 01:13 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              19 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              11 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-07-2026, 11:05 AM
              0 responses
              28 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-02-2026, 11:08 AM
              0 responses
              31 views
              0 reactions
              Last Post SEQadmin2  
              Working...